QR678, a globally patented scalp science and regenerative hair regeneration research platform, has received regulatory approvals in Malaysia for three of its patented hair regenerative products, marking a major step in the company’s expansion across East Asia.
The approvals cover QR678 PREO, QR678 NEO and QR678 ZEO, and were granted under Malaysia’s Control of Drugs and Cosmetics Regulations administered by the Ministry of Health Malaysia.
The move enables the company to formally introduce the products in Malaysia in line with local cosmetic product requirements and establish partnerships with local distributors, dermatology practices, aesthetic clinics and wellness providers.
According to the company, the Malaysian approvals represent an important milestone in the international expansion of products developed through the QR678 research ecosystem and highlight the growing recognition of Indian-origin innovation in cosmetic science and aesthetic care.
Dr Khushbu Jamasbi, Senior Manager, QR678 Malaysia, said, “The approvals in Malaysia create an opportunity to expand access to QR678 PREO, QR678 NEO and QR678 ZEO through commercial partnerships while continuing to demonstrate how patented research and development can contribute meaningfully to global advances in cosmetic science and regenerative aesthetics.”
The company said each of the newly approved products has been built around a specific formulation philosophy designed to support structured biological signalling and protocol-driven application.
“QR678 PREO focuses on precision and reproducibility, QR678 NEO on network organisation, and QR678 ZEO on pathway orchestration. Together, they reflect the QR678 brand’s long-term focus on creating standardised and structured formulation environments designed around consistency, biological organisation and clinician-guided use,” it stated.
Developed over more than 18 years of research and clinical innovation, the QR678 platform has evolved from an Indian research initiative into a globally patented platform focused on hair biology and regenerative aesthetics.
The company said its formulations are currently used by more than 5,000 dermatologists, aesthetic physicians and hair restoration specialists across over 2,000 clinics in more than 10 countries, reaching over 150,000 patients globally. QR678 also stated that it has filed five additional global patent applications in 2025.
With the global hair restoration market projected to reach USD 8.71 billion in 2026, and Asia-Pacific emerging as one of the fastest-growing regions for aesthetic and wellness services, QR678 sees Malaysia as a strategic market for further growth.
“Malaysia represents an important milestone for QR678, but the larger significance lies in the continued global acceptance of structured and scientifically developed platform approaches within hair biology and aesthetic medicine,” Dr Jamasbi added.
QR678 said its research platform focuses on structured formulation approaches designed around hair regeneration reproducibility, biological organisation and protocol-driven application, with continued research supporting developments in hair biology, aesthetic medicine and regenerative science.
